Together, these data substantiate the hypothesis that FPHPE exerts anti‐inflammatory and anti‐tumor effects through targeted inhibition of the JAK2/STAT3 signaling cascade, reinforcing its potential as a dual‐action therapeutic agent in HCC management. This evidence concerns the gene JAK2 and hepatocellular carcinoma.